Zheng Quan Ri Bao Wang·2026-01-21 04:09Core Insights - Artificial intelligence (AI) is deeply integrated into the healthcare system, driving high-quality development in the industry [1] - The competition in the medical AI sector is intensifying among internet healthcare companies and tech firms [1] - Companies like JD Health and Alibaba Health are advancing from "single-point tools" to "ecosystem competition" [1] Company Developments - JD Health launched the evidence-based medicine AI tool "ZhiYi" aimed at doctors, which is considered a Chinese version of "OpenEvidence" [1] - Alibaba Health's AI product "Hydrogen Ion" has completed internal testing and is designed to be the lowest hallucination rate AI assistant in the medical field [1] - Health 160 has developed a dual-driven model combining public and private WeChat accounts to enhance digital healthcare services [2] Technological Advancements - Health 160 has tested an AI health steward multi-agent system covering pre-diagnosis, diagnosis, and post-diagnosis scenarios [3] - JD Health aims to evolve internet healthcare into a core engine for precise, personalized, and comprehensive health management [3] - OpenAI's ChatGPT for Healthcare has been deployed in various institutions, emphasizing data integration and personalized experiences [2] Industry Trends - The focus of AI healthcare competition has shifted from "usefulness" to "stable, compliant, and sustainable implementation" [3] - Future trends in China's AI healthcare include a complementary relationship between major players' full-chain layouts and precise niche market cultivation [4] - The industry is expected to transition from a "treatment-oriented" approach to "proactive health" as technology matures [4]